Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001326389-25-000192
Filing Date
2025-05-15
Accepted
2025-05-15 07:12:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4962
  Complete submission text file 0001326389-25-000192.txt   6686
Mailing Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6
Business Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6 416-367-4364
Polar Asset Management Partners Inc. (Filed by) CIK: 0001326389 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SCHEDULE 13G

Mailing Address 2 PELICAN DR. FORT LAUDERDALE FL 33301
Business Address 2 PELICAN DR. FORT LAUDERDALE FL 33301 954-870-3104
Drugs Made In America Acquisition Corp. (Subject) CIK: 0002028614 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94909 | Film No.: 25948666
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)